Drug Profile
BMS 181168
Alternative Names: BMY 21502Latest Information Update: 15 Nov 1994
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Nootropics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease